SHELLEY SMITH: Open Payments
NPI 1881149102 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 55 payments from 17 companies in 2025. Trend: 2023 $852 · 2024 $636 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $166 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $145 |
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $57 |
| HEARTFLOW, INC. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| PFIZER INC. | 1 | $26 |
Products named: REPATHA, Kerendia, JARDIANCE, LEQVIO, LifeVest, FFRct, INSPIRE, ENTRESTO.
Industry payments across GA — which companies pay providers there.
